Summary by Futu AI
AIDEMIO MATERNAL AND INFANT HEALTH CO., LTD. (“AIDOMIO”) ANNOUNCES THAT ITS SHARE OFFERING RESULTS SHOW THAT THE MAXIMUM NUMBER OF SHARES IS 3,663,812,035 SHARES, CORRESPONDING TO 1,478,338,324 SHARES AVAILABLE FOR SUBSCRIPTION BY THE FINAL ACCEPTANCE DEADLINE OF MAY 6, 2024. The total is about 247.83%. Of these, 1,234,078,384 shares are valid under the provisional quota notice, 2,429,733,651 shares are valid under the supplementary application form, and the oversubscribed share is 2,185,473,711 shares. Since the number of valid applications for additional shares far exceeds the number available for subscription, it is allocated to eligible shareholders at a ratio of approximately 10.05%. THE OUTSOURCING AGREEMENT BECAME UNCONDITIONAL ON 7 MAY 2024 AND THE NET PROCEEDS RAISED FOR SHARES OF APPROXIMATELY HK$56.30 MILLION WILL BE USED AS DISCLOSED IN THE SHARE PLAN. The shares are expected to start trading on the exchange on 16 May 2024. In addition, the Company's Class A and Class B Convertible Preferred Stock Exchange Price has been adjusted to issue an additional 113,147,266 shares.